Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Phylogica Announces Operational Update - June Quarter (ASX:PYC)

PYC is pleased to update shareholders on progress made in the June quarter. Highlights: - Successful completion of the proof of concept validation for our intracellular delivery platform across ...read more

Phylogica Announces Achievement of Major Milestone - Successful In Vivo Cre Delivery (ASX:PYC)

PYC is pleased to announce the successful achievement of a major technical milestone in the validation of its intracellular drug delivery platform. Highlights: - PYC has successfully delivered t...read more

Phylogica Announces Successful In Vivo Results - Peptide Vaccine T-cell Expansion (ASX:PYC)

PYC is pleased to announce successful in vivo results in the evaluation of its peptide vaccine program. Highlights: - PYC’s Cell Penetrating Peptides (CPPs) elicit a substantially stronger...read more

Phylogica Announces Peer Reviewed Journal Publication (ASX:PYC)

Phylogica (ASX:PYC) is the owner of a peptide library containing the extraordinary richness and diversity of nature. We are using these libraries to develop a drug delivery platform capable of reachin...read more

Phylogica announces Change in substantial holding (ASX:PYC)

Notice of change of interests of substantial holder For further information please download PDF attached:

Phylogica announces CEO Update (ASX:PYC)

Phylogica (ASX:PYC) is the owner of a peptide library containing the extraordinary richness and diversity of nature and is using these libraries to develop a delivery platform capable of reaching the ...read more

Phylogica Announces Chief Executive Officer - Employment Terms (ASX:PYC)

Phylogica Limited (Phylogica or the Company) is pleased to advise that the terms of Dr Rohan Hockings engagement as Chief Executive Officer (CEO) have been finalised. The announcement of Dr Hocking...read more

Phylogica Limited announces Investor Presentation - May 2018 (ASX:PYC)

Phylogica Limited (ASX:PYC) Investor Presentation - May 2018 To view the presentation please download PDF attached:

Phylogica, Appendix 3B (ASX:PYC)

Phylogica Limited (ASX:PYC) (Phylogica or the Company), submits the following Appendix 3B in relation to the cancellation of unlisted options. For further information please download PDF attached...read more

Phylogica, Trading Policy (ASX:PYC)

Phylogica Limited (ASX:PYC) (Phylogica or the Company), submits an amended Trading Policy pursuant to Listing Rule 12.10. To view Policy please download PDF attached:

Phylogica, Appendix 3Z (ASX:PYC)

Phylogica Limited (ASX:PYC) (Phylogica or the Company), submits the following Appendix in relation to a Final Directors interest: Appendix 3Z – Final Director’s Interest Notice – ...read more

Phylogica, Operational Update - March Quarter Investor Call (ASX:PYC)

PERTH, Australia, 30 April 2018: Phylogica Limited (ASX:PYC) (Phylogica or the Company), invites shareholders and other interested parties to join a conference call next Monday May 7, accompanying Phy...read more

Phylogica, Operational Update - March Quarter (ASX:PYC)

PERTH, Australia, 30 April 2018: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to update shareholders on pr...read more

Phylogica, Appendix 3X and 3Y (ASX:PYC)

Phylogica Limited (ASX:PYC) (Phylogica or the Company), submits the following Appendices in relation to an Initial Directors interest and a Change in Director’s interests: Appendix 3X –...read more